NAGIOS: RODERIC FUNCIONANDO

Effects of Estrogen on vascular inflammation: a matter of timing.

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Effects of Estrogen on vascular inflammation: a matter of timing.

Mostra el registre parcial de l'element

dc.contributor.author Novella, Susana
dc.contributor.author Heras, Magda
dc.contributor.author Hermenegildo, Carlos
dc.contributor.author Dantas, A. P.
dc.date.accessioned 2020-09-30T18:21:19Z
dc.date.available 2020-09-30T18:21:19Z
dc.date.issued 2012
dc.identifier.citation Novella, Susana Heras, Magda Hermenegildo, Carlos Dantas, A. P. 2012 Effects of Estrogen on vascular inflammation: a matter of timing. Arteriosclerosis Thrombosis and Vascular Biology 32 2035 2042
dc.identifier.uri https://hdl.handle.net/10550/75711
dc.description.abstract Objective: Our study aims to determine the role of time of menopause on vascular inflammation biomarkers and how it affects their modulation by estrogen and raloxifene in postmenopausal women. Methods and results: Uterine arteries from 68 postmenopausal women were divided into 3 segments and cultured for 24 hours in tissue culture media containing 17β-estradiol (100 nmol/L), raloxifene (100 nmol/L), or vehicle. Assessment of arterial concentration of 13 inflammatory biomarkers was performed by multiplex immunobead-based assay. Aging per se has a positive correlation with the generation of several proinflammatory markers. Although short-term estradiol exposure correlates with lower expression of tumor necrosis factor-α, vascular endothelial growth factor, and interleukin-1β in all age groups, for most biomarkers aging was associated with a switch from a beneficial anti-inflammatory action by estrogen, at earlier stages of menopause, to a proinflammatory profile after 5 years past its onset. Raloxifene has no significant effect on the expression of all proinflammatory markers. Western blot analysis of estrogen receptor expression (estrogen receptor-α and estrogen receptor-β) showed that estrogen receptor-β increases with aging, and this increase has a positive correlation with the generation of several proinflammatory markers. Conclusions: Aging alters estrogen-mediated effects on the modulation of inflammatory biomarkers in women. How aging affects estrogen responses on vascular inflammation is not clear, but our data show a positive association between increased estrogen receptor-β expression with aging and proinflammatory effects by estrogen.
dc.language.iso eng
dc.relation.ispartof Arteriosclerosis Thrombosis and Vascular Biology, 2012, vol. 32, p. 2035-2042
dc.subject Hormones esteroides
dc.subject Menopausa
dc.title Effects of Estrogen on vascular inflammation: a matter of timing.
dc.type journal article es_ES
dc.date.updated 2020-09-30T18:21:19Z
dc.identifier.doi 10.1161/ATVBAHA.112.250308
dc.identifier.idgrec 081272
dc.rights.accessRights open access es_ES

Visualització       (873.0Kb)

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a RODERIC

Cerca avançada

Visualitza

Estadístiques